Even though one-half of patients have chromosomal abnormalities, the other half are cytogenetically normal (CN-AML), carrying recurrent somatic mutations in several oncogenes (NPM1, FLT3, CEBPA) [2]. This evidence concerns the gene FLT3 and acute myeloid leukemia.